LABCORP HOLDINGS INC. Dividends Declared
LABCORP HOLDINGS INC. (LH) reported Dividends Declared of $58.40 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Shareholders' Equity
us-gaap:Dividends · last filed 2026-08-05
- LABCORP HOLDINGS INC. dividends for the quarter ending 2026-06-30 was $58.40M, a 2.99% decline year-over-year.
- LABCORP HOLDINGS INC. dividends for the quarter ending 2026-03-31 was $60.20M, a 0.66% decline year-over-year.
- LABCORP HOLDINGS INC. dividends for the quarter ending 2025-09-30 was $60.70M, a 0.65% decline year-over-year.
- LABCORP HOLDINGS INC. dividends for the quarter ending 2025-06-30 was $60.20M, a 0.00% change year-over-year.
- LABCORP HOLDINGS INC. dividends for fiscal 2025 was $241.10M, a 0.74% decline from fiscal 2024.
- LABCORP HOLDINGS INC. dividends for fiscal 2024 was $242.90M, a 5.15% decline from fiscal 2023.
- LABCORP HOLDINGS INC. dividends for fiscal 2023 was $256.10M, a 28.89% increase from fiscal 2022.
- LABCORP HOLDINGS INC. dividends for fiscal 2022 was $198.70M.
| Period end | Dividends 3 month | Dividends 6 month | Dividends 9 month | Dividends 12 month |
|---|---|---|---|---|
| 2026-06-30 | $58.40M 10-Q · filed 2026-08-05 | $118.60M derived: sum of 2 quarters · filed 2026-08-05 | ||
| 2026-03-31 | $60.20M 10-Q · filed 2026-08-05 | |||
| 2025-12-31 | $241.10M 10-K · filed 2026-02-24 | |||
| 2025-09-30 | $60.70M 10-Q · filed 2025-10-31 | $120.90M derived: sum of 2 quarters · filed 2026-08-05 | $181.50M derived: sum of 3 quarters · filed 2026-08-05 | |
| 2025-06-30 | $60.20M 10-Q · filed 2026-08-05 | $120.80M derived: sum of 2 quarters · filed 2026-08-05 | ||
| 2025-03-31 | $60.60M 10-Q · filed 2026-08-05 | |||
| 2024-12-31 | $242.90M 10-K · filed 2026-02-24 | |||
| 2024-09-30 | $61.10M 10-Q · filed 2025-10-31 | $121.30M derived: sum of 2 quarters · filed 2025-10-31 | $182.20M derived: sum of 3 quarters · filed 2025-10-31 | |
| 2024-06-30 | $60.20M 10-Q · filed 2025-10-31 | $121.10M derived: sum of 2 quarters · filed 2025-10-31 | ||
| 2024-03-31 | $60.90M 10-Q · filed 2025-10-31 | |||
| 2023-12-31 | $256.10M 10-K · filed 2026-02-24 | |||
| 2023-09-30 | $64.60M 10-Q · filed 2023-10-30 | $129.10M derived: sum of 2 quarters · filed 2023-10-30 | $193.80M derived: sum of 3 quarters · filed 2024-10-29 | |
| 2023-06-30 | $64.50M 10-Q · filed 2023-10-30 | $129.20M derived: sum of 2 quarters · filed 2024-10-29 | ||
| 2023-03-31 | $64.70M 10-Q · filed 2024-10-29 | |||
| 2022-12-31 | $198.70M 10-K · filed 2025-02-25 | |||
| 2022-09-30 | $131.60M 10-Q · filed 2022-11-01 | $198.30M derived: sum of 2 quarters · filed 2022-11-01 | ||
| 2022-06-30 | $66.70M 10-Q · filed 2022-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |